Trial Profile
A Single Dose Pharmacokinetic Study of Dulaglutide in Subjects With Varying Degrees of Renal Impairment
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2014
Price :
$35
*
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 04 Nov 2014 New trial record
- 19 Sep 2014 Results of this and another phase 1 trial presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.